{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T13:48:12Z","timestamp":1788875292800,"version":"build-2803163510"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,4,16]]},"DOI":"10.7759\/cureus.82365","type":"journal-article","created":{"date-parts":[[2025,4,16]],"date-time":"2025-04-16T13:09:11Z","timestamp":1744808951000},"source":"Crossref","is-referenced-by-count":1,"title":["Prevalence and Clinical Correlation of Intron 22 Inversion in Hemophilia A in Northeast India"],"prefix":"10.7759","author":[{"given":"Ruby","family":"Barman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adity","family":"Sarma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zarika","family":"Ahmed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anupam","family":"Dutta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1177\/1076029619888293","article-title":"Identification of the intron 22 and intron 1 inversions of the factor VIII gene in Iraqi Kurdish patients with hemophilia A","volume":"26","author":"Abdulqader AM","year":"2020","unstructured":"Abdulqader AM, Mohammed AI, Rachid S, Ghoraishizadeh P, Mahmood SN. Identification of the intron 22 and intron 1 inversions of the factor VIII gene in Iraqi Kurdish patients with hemophilia A. Clin Appl Thromb Hemost. 2020, 26:1076029619888293. 10.1177\/1076029619888293","journal-title":"Clin Appl Thromb Hemost"},{"key":"ref2","doi-asserted-by":"crossref","DOI":"10.1182\/blood.V84.7.2197.2197","article-title":"Analysis of intron 22 inversions of the factor VIII gene in severe hemophilia A: implications for genetic counseling","volume":"84","author":"Jenkins PV","year":"1994","unstructured":"Jenkins PV, Collins PW, Goldman E, et al.. Analysis of intron 22 inversions of the factor VIII gene in severe hemophilia A: implications for genetic counseling. Blood. 1994, 84:2197-201.","journal-title":"Blood"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1186\/s13052-020-00878-5","article-title":"Factor VIII inhibitor development in Egyptian hemophilia patients: does intron 22 inversion mutation play a role?","volume":"46","author":"Sherief LM","year":"2020","unstructured":"Sherief LM, Gaber OA, Youssef HM, et al.. Factor VIII inhibitor development in Egyptian hemophilia patients: does intron 22 inversion mutation play a role?. Ital J Pediatr. 2020, 46:129. 10.1186\/s13052-020-00878-5","journal-title":"Ital J Pediatr"},{"key":"ref4","article-title":"Prevalence of the intron 22 inversion of the factor VIII gene and inhibitor development in Polish patients with severe hemophilia A","volume":"53","author":"Sawecka J","year":"2005","unstructured":"Sawecka J, Skulimowska J, Windyga J, et al.. Prevalence of the intron 22 inversion of the factor VIII gene and inhibitor development in Polish patients with severe hemophilia A. Arch Immunol Ther Exp. 2005, 53:352-6.","journal-title":"Arch Immunol Ther Exp"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1128641","article-title":"Hemophilia A subjects with an intron-22 gene inversion mutation show CD4(+) T-effector responses to multiple epitopes in FVIII","volume":"14","author":"Gunasekera D","year":"2023","unstructured":"Gunasekera D, Vir P, Karim AF, Ragni MV, Pratt KP. Hemophilia A subjects with an intron-22 gene inversion mutation show CD4(+) T-effector responses to multiple epitopes in FVIII. Front Immunol. 2023, 14:1128641. 10.3389\/fimmu.2023.1128641","journal-title":"Front Immunol"},{"key":"ref6","doi-asserted-by":"crossref","DOI":"10.1182\/blood.V96.8.2905","article-title":"De novo factor VIII gene intron 22 inversion in a female carrier presents as a somatic mosaicism","volume":"96","author":"Oldenburg J","year":"2000","unstructured":"Oldenburg J, Rost S, El-Maarri O, et al.. De novo factor VIII gene intron 22 inversion in a female carrier presents as a somatic mosaicism. Blood. 2000, 96:2905-6.","journal-title":"Blood"},{"key":"ref7","article-title":"F8 gene mutation type and inhibitor development in patients with severe hemophilia A: systematic review and meta-analysis","volume":"119","author":"Gouw SC","year":"2012","unstructured":"Gouw SC, van den Berg HM, Oldenburg J, et al.. F8 gene mutation type and inhibitor development in patients with severe hemophilia A: systematic review and meta-analysis. Blood. 2012, 119:2922-34.","journal-title":"Blood"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2516.2009.02127.x","article-title":"A study of variations in the reported haemophilia A prevalence around the world","volume":"16","author":"Stonebraker JS","year":"2010","unstructured":"Stonebraker JS, Bolton-Maggs PH, Soucie JM, Walker I, Brooker M. A study of variations in the reported haemophilia A prevalence around the world. Haemophilia. 2010, 16:20-32. 10.1111\/j.1365-2516.2009.02127.x","journal-title":"Haemophilia"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2516.2012.02909.x","article-title":"Guidelines for the management of hemophilia","volume":"19","author":"Srivastava A","year":"2013","unstructured":"Srivastava A, Brewer AK, Mauser-Bunschoten EP, et al.. Guidelines for the management of hemophilia. Haemophilia. 2013, 19:e1-47. 10.1111\/j.1365-2516.2012.02909.x","journal-title":"Haemophilia"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM200106073442307","article-title":"The hemophilias-from royal genes to gene therapy","volume":"344","author":"Mannucci PM","year":"2001","unstructured":"Mannucci PM, Tuddenham EG. The hemophilias-from royal genes to gene therapy. N Engl J Med. 2001, 344:1773-9. 10.1056\/NEJM200106073442307","journal-title":"N Engl J Med"},{"key":"ref11","unstructured":"National Hemophilia Foundation. MASAC Document 290-MASAC recommendations concerning products licensed for the treatment of hemophilia and selected disorders of the coagulation system. (2023). Accessed. January 22, 2025: https:\/\/www.bleeding.org\/healthcare-professionals\/guidelines-on-care\/masac-documents\/masac-document-290-masac-recomme...."},{"key":"ref12","doi-asserted-by":"crossref","DOI":"10.1182\/blood.V86.6.2206.bloodjournal8662206","article-title":"Factor VIII gene inversions in severe hemophilia A: results of an international consortium study","volume":"86","author":"Antonarakis SE","year":"1995","unstructured":"Antonarakis SE, Rossiter JP, Young M, et al.. Factor VIII gene inversions in severe hemophilia A: results of an international consortium study. Blood. 1995, 86:2206-12.","journal-title":"Blood"},{"key":"ref13","doi-asserted-by":"crossref","DOI":"10.1093\/hmg\/4.7.1217","article-title":"Investigation of the factor VIII intron 22 repeated region (int22h) and the associated inversion junctions","volume":"4","author":"Naylor JA","year":"1995","unstructured":"Naylor JA, Buck D, Green P, et al.. Investigation of the factor VIII intron 22 repeated region (int22h) and the associated inversion junctions. Hum Mol Genet. 1995, 4:1217-24.","journal-title":"Hum Mol Genet"},{"key":"ref14","doi-asserted-by":"crossref","DOI":"10.1182\/blood.V99.1.168","article-title":"Recurrent inversion breaking intron 1 of the factor VIII gene is a frequent cause of severe hemophilia A","volume":"99","author":"Bagnall RD","year":"2002","unstructured":"Bagnall RD, Waseem N, Green PM, et al.. Recurrent inversion breaking intron 1 of the factor VIII gene is a frequent cause of severe hemophilia A. Blood. 2002, 99:168-74.","journal-title":"Blood"},{"key":"ref15","doi-asserted-by":"crossref","DOI":"10.1038\/ng1193-236","article-title":"Inversions disrupting the factor VIII gene are a common cause of severe haemophilia A","volume":"5","author":"Lakich D","year":"1993","unstructured":"Lakich D, Kazazian HH Jr, Antonarakis SE, et al.. Inversions disrupting the factor VIII gene are a common cause of severe haemophilia A. Nat Genet. 1993, 5:236-41.","journal-title":"Nat Genet"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.2007.06657.x","article-title":"Inhibitor development in haemophilia B: an orphan disease in need of attention","volume":"138","author":"DiMichele DM","year":"2007","unstructured":"DiMichele DM. Inhibitor development in haemophilia B: an orphan disease in need of attention. Br J Haematol. 2007, 138:305-15. 10.1111\/j.1365-2141.2007.06657.x","journal-title":"Br J Haematol"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0609.2010.01481.x","article-title":"Factor VIII gene mutations profile in 148 Chinese hemophilia A subjects","volume":"85","author":"Xue F","year":"2010","unstructured":"Xue F, Zhang L, Sui T, et al.. Factor VIII gene mutations profile in 148 Chinese hemophilia A subjects. Eur J Haematol. 2010, 85:264-72. 10.1111\/j.1600-0609.2010.01481.x","journal-title":"Eur J Haematol"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2516.2005.01121.x","article-title":"Identification of factor VIII gene mutations in 101 patients with haemophilia A: mutation analysis by inversion screening and multiplex PCR and CSGE and molecular modelling of 10 novel missense substitutions","volume":"11","author":"Jayandharan G","year":"2005","unstructured":"Jayandharan G, Shaji RV, Baidya S, Nair SC, Chandy M, Srivastava A. Identification of factor VIII gene mutations in 101 patients with haemophilia A: mutation analysis by inversion screening and multiplex PCR and CSGE and molecular modelling of 10 novel missense substitutions. Haemophilia. 2005, 11:481-91. 10.1111\/j.1365-2516.2005.01121.x","journal-title":"Haemophilia"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1007\/s00277-010-1115-x","article-title":"Genotyping of intron 22-related rearrangements of F8 by inverse-shifting PCR in Egyptian hemophilia A patients","volume":"90","author":"Abou-Elew H","year":"2011","unstructured":"Abou-Elew H, Ahmed H, Raslan H, Abdelwahab M, Hammoud R, Mokhtar D, Arnaout H. Genotyping of intron 22-related rearrangements of F8 by inverse-shifting PCR in Egyptian hemophilia A patients. Ann Hematol. 2011, 90:579-84. 10.1007\/s00277-010-1115-x","journal-title":"Ann Hematol"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1007\/s11239-020-02043-5","article-title":"Rapid genotyping of F8 intron 22 inversion by nested PCR based on long-distance PCR","volume":"49","author":"Wang X","year":"2020","unstructured":"Wang X, Hu W, Gao Y, Li D, Lu Y. Rapid genotyping of F8 intron 22 inversion by nested PCR based on long-distance PCR. J Thromb Thrombolysis. 2020, 49:591-601. 10.1007\/s11239-020-02043-5","journal-title":"J Thromb Thrombolysis"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1111\/hae.13633","article-title":"Prevalence of FVIII inhibitors in severe haemophilia A patients: effect of treatment and genetic factors in an Indian population","volume":"25","author":"David S","year":"2019","unstructured":"David S, Nair SC, Singh GS, et al.. Prevalence of FVIII inhibitors in severe haemophilia A patients: effect of treatment and genetic factors in an Indian population. Haemophilia. 2019, 25:67-74. 10.1111\/hae.13633","journal-title":"Haemophilia"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1007\/s12288-011-0084-0","article-title":"Hemophilia care in India: a review and experience from a tertiary care centre in Uttar Pradesh","volume":"27","author":"Phadke S","year":"2011","unstructured":"Phadke S. Hemophilia care in India: a review and experience from a tertiary care centre in Uttar Pradesh. Indian J Hematol Blood Transfus. 2011, 27:121-6. 10.1007\/s12288-011-0084-0","journal-title":"Indian J Hematol Blood Transfus"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1002\/humu.1380050102","article-title":"Molecular etiology of factor VIII deficiency in hemophilia A","volume":"5","author":"Antonarakis SE","year":"1995","unstructured":"Antonarakis SE, Kazazian HH, Tuddenham EG. Molecular etiology of factor VIII deficiency in hemophilia A. Hum Mutat. 1995, 5:1-22. 10.1002\/humu.1380050102","journal-title":"Hum Mutat"},{"key":"ref24","article-title":"Intron 22 inversion real-time polymerase chain reaction detection in haemophilia A families from central South Africa","volume":"109","author":"Kloppers JF","year":"2019","unstructured":"Kloppers JF, Marx GM, Janse van Rensburg WJ. Intron 22 inversion real-time polymerase chain reaction detection in haemophilia A families from central South Africa. SAMJ, S Afr Med J. 2019, 109:876-9. 107196\/samj.2019.v109i11.13979","journal-title":"SAMJ, S Afr Med J"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1111\/hae.12924","article-title":"Identification of mutations in the F8 and F9 gene in families with haemophilia using targeted high-throughput sequencing","volume":"22","author":"Lyu C","year":"2016","unstructured":"Lyu C, Xue F, Liu X, et al.. Identification of mutations in the F8 and F9 gene in families with haemophilia using targeted high-throughput sequencing. Haemophilia. 2016, 22:e427-34. 10.1111\/hae.12924","journal-title":"Haemophilia"},{"key":"ref26","article-title":"Analysis of large structural changes of the factor VIII gene, involving intron 1 and 22, in severe hemophilia A","volume":"88","author":"Andrikovics H","year":"2003","unstructured":"Andrikovics H, Klein I, Bors A, Nemes L, Marosi A, V\u00e1radi A, Tordai A. Analysis of large structural changes of the factor VIII gene, involving intron 1 and 22, in severe hemophilia A. Haematologica. 2003, 88:778-84.","journal-title":"Haematologica"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.14740\/jocmr2876w","article-title":"Molecular analysis of factor VIII and factor IX genes in hemophilia patients: identification of novel mutations and molecular dynamics studies","volume":"9","author":"Al-Allaf FA","year":"2017","unstructured":"Al-Allaf FA, Taher MM, Abduljaleel Z, et al.. Molecular analysis of factor VIII and factor IX genes in hemophilia patients: identification of novel mutations and molecular dynamics studies. J Clin Med Res. 2017, 9:317-31. 10.14740\/jocmr2876w","journal-title":"J Clin Med Res"},{"key":"ref28","unstructured":"World Federation of Hemophilia. Report on annual global survey. (2022). Accessed. January 22, 2025: https:\/\/www.wfh.org\/en\/our-work\/research-data\/annual-global-survey\/."},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2006-11-056291","article-title":"Treatment-related risk factors of inhibitor development in previously untreated patients with hemophilia A: the CANAL cohort study","volume":"109","author":"Gouw SC","year":"2007","unstructured":"Gouw SC, van der Bom JG, Marijke van den Berg H. Treatment-related risk factors of inhibitor development in previously untreated patients with hemophilia A: the CANAL cohort study. Blood. 2007, 109:4648-54. 10.1182\/blood-2006-11-056291","journal-title":"Blood"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/349271-prevalence-and-clinical-correlation-of-intron-22-inversion-in-hemophilia-a-in-northeast-india","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,16]],"date-time":"2025-04-16T13:09:14Z","timestamp":1744808954000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/349271-prevalence-and-clinical-correlation-of-intron-22-inversion-in-hemophilia-a-in-northeast-india"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,16]]},"references-count":29,"URL":"https:\/\/doi.org\/10.7759\/cureus.82365","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,4,16]]}}}